These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26134519)

  • 1. A Fine Balance of Dietary Lipids Improves Pathology of a Murine Model of VCP-Associated Multisystem Proteinopathy.
    Llewellyn KJ; Walker N; Nguyen C; Tan B; BenMohamed L; Kimonis VE; Nalbandian A
    PLoS One; 2015; 10(7):e0131995. PubMed ID: 26134519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid-enriched diet rescues lethality and slows down progression in a murine model of VCP-associated disease.
    Llewellyn KJ; Nalbandian A; Jung KM; Nguyen C; Avanesian A; Mozaffar T; Piomelli D; Kimonis VE
    Hum Mol Genet; 2014 Mar; 23(5):1333-44. PubMed ID: 24158850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The homozygote VCP(R¹⁵⁵H/R¹⁵⁵H) mouse model exhibits accelerated human VCP-associated disease pathology.
    Nalbandian A; Llewellyn KJ; Kitazawa M; Yin HZ; Badadani M; Khanlou N; Edwards R; Nguyen C; Mukherjee J; Mozaffar T; Watts G; Weiss J; Kimonis VE
    PLoS One; 2012; 7(9):e46308. PubMed ID: 23029473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro studies in VCP-associated multisystem proteinopathy suggest altered mitochondrial bioenergetics.
    Nalbandian A; Llewellyn KJ; Gomez A; Walker N; Su H; Dunnigan A; Chwa M; Vesa J; Kenney MC; Kimonis VE
    Mitochondrion; 2015 May; 22():1-8. PubMed ID: 25724235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise training reverses skeletal muscle atrophy in an experimental model of VCP disease.
    Nalbandian A; Nguyen C; Katheria V; Llewellyn KJ; Badadani M; Caiozzo V; Kimonis VE
    PLoS One; 2013; 8(10):e76187. PubMed ID: 24130765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceramide contributes to pathogenesis and may be targeted for therapy in VCP inclusion body myopathy.
    Weiss L; Jung KM; Nalbandian A; Llewellyn K; Yu H; Ta L; Chang I; Migliore M; Squire E; Ahmed F; Piomelli D; Kimonis V
    Hum Mol Genet; 2021 Feb; 29(24):3945-3953. PubMed ID: 33410456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted excision of VCP R155H mutation by Cre-LoxP technology as a promising therapeutic strategy for valosin-containing protein disease.
    Nalbandian A; Llewellyn KJ; Nguyen C; Monuki ES; Kimonis VE
    Hum Gene Ther Methods; 2015 Feb; 26(1):13-24. PubMed ID: 25545721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapamycin and chloroquine: the in vitro and in vivo effects of autophagy-modifying drugs show promising results in valosin containing protein multisystem proteinopathy.
    Nalbandian A; Llewellyn KJ; Nguyen C; Yazdi PG; Kimonis VE
    PLoS One; 2015; 10(4):e0122888. PubMed ID: 25884947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VCP maintains lysosomal homeostasis and TFEB activity in differentiated skeletal muscle.
    Arhzaouy K; Papadopoulos C; Schulze N; Pittman SK; Meyer H; Weihl CC
    Autophagy; 2019 Jun; 15(6):1082-1099. PubMed ID: 30654731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mTOR dysfunction contributes to vacuolar pathology and weakness in valosin-containing protein associated inclusion body myopathy.
    Ching JK; Elizabeth SV; Ju JS; Lusk C; Pittman SK; Weihl CC
    Hum Mol Genet; 2013 Mar; 22(6):1167-79. PubMed ID: 23250913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of the novel Vcp (valosin containing protein) interactor Washc4 interferes with autophagy-mediated proteostasis in striated muscle and leads to myopathy in vivo.
    Kustermann M; Manta L; Paone C; Kustermann J; Lausser L; Wiesner C; Eichinger L; Clemen CS; Schröder R; Kestler HA; Sandri M; Rottbauer W; Just S
    Autophagy; 2018; 14(11):1911-1927. PubMed ID: 30010465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The heterozygous R155C VCP mutation: Toxic in humans! Harmless in mice?
    Clemen CS; Winter L; Strucksberg KH; Berwanger C; Türk M; Kornblum C; Florin A; Aguilar-Pimentel JA; Amarie OV; Becker L; Garrett L; Hans W; Moreth K; Neff F; Pingen L; Rathkolb B; Rácz I; Rozman J; Treise I; Fuchs H; Gailus-Durner V; de Angelis MH; Vorgerd M; Eichinger L; Schröder R
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2770-2777. PubMed ID: 30100055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the Asian myopathy patients with VCP mutations.
    Shi Z; Hayashi YK; Mitsuhashi S; Goto K; Kaneda D; Choi YC; Toyoda C; Hieda S; Kamiyama T; Sato H; Wada M; Noguchi S; Nonaka I; Nishino I
    Eur J Neurol; 2012 Mar; 19(3):501-9. PubMed ID: 22040362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenic variants of Valosin-containing protein induce lysosomal damage and transcriptional activation of autophagy regulators in neuronal cells.
    Ferrari V; Cristofani R; Cicardi ME; Tedesco B; Crippa V; Chierichetti M; Casarotto E; Cozzi M; Mina F; Galbiati M; Piccolella M; Carra S; Vaccari T; Nalbandian A; Kimonis V; Fortuna TR; Pandey UB; Gagliani MC; Cortese K; Rusmini P; Poletti A
    Neuropathol Appl Neurobiol; 2022 Aug; 48(5):e12818. PubMed ID: 35501124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myogenic differentiation of VCP disease-induced pluripotent stem cells: A novel platform for drug discovery.
    Llewellyn KJ; Nalbandian A; Weiss LN; Chang I; Yu H; Khatib B; Tan B; Scarfone V; Kimonis VE
    PLoS One; 2017; 12(6):e0176919. PubMed ID: 28575052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valosin-containing protein (VCP) is a novel IQ motif-containing GTPase activating protein 1 (IQGAP1)-interacting protein.
    Itoh N; Nagai T; Watanabe T; Taki K; Nabeshima T; Kaibuchi K; Yamada K
    Biochem Biophys Res Commun; 2017 Dec; 493(4):1384-1389. PubMed ID: 28970065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone.
    Custer SK; Neumann M; Lu H; Wright AC; Taylor JP
    Hum Mol Genet; 2010 May; 19(9):1741-55. PubMed ID: 20147319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas9-Mediated Constitutive Loss of VCP (Valosin-Containing Protein) Impairs Proteostasis and Leads to Defective Striated Muscle Structure and Function In Vivo.
    Voisard P; Diofano F; Glazier AA; Rottbauer W; Just S
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inclusion body myopathy with Paget's disease of bone and frontotemporal dementia].
    Hayashi Y
    Rinsho Shinkeigaku; 2013; 53(11):947-50. PubMed ID: 24291843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One family, one gene and three phenotypes: A novel VCP (valosin-containing protein) mutation associated with myopathy with rimmed vacuoles, amyotrophic lateral sclerosis and frontotemporal dementia.
    Abrahao A; Abath Neto O; Kok F; Zanoteli E; Santos B; Pinto WB; Barsottini OG; Oliveira AS; Pedroso JL
    J Neurol Sci; 2016 Sep; 368():352-8. PubMed ID: 27538664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.